According to Novartis latest financial reports the total debt is $20.03B, an decrease of -8.02% to 2022. At the end of 2022 company had $21.78B total debt. This figure represents the debts and financial obligations that Novartis combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $20.03B | -8.02% |
2022 | $21.78B | -11.18% |
2021 | $24.52B | -12.35% |
2020 | $27.98B | 26.85% |
2019 | $22.06B | -1.84% |
2018 | $22.47B | - |